The use of a new selective AB3 aptamer for the hematologic tumor cells’ detection

Abstract

Hematologic malignancies represent cancer diseases that affect the bone marrow and blood cells and include various subtypes depending mostly on the morphology of the cells. It is well known that an early diagnosis could be very useful for increasing survival rates in cancer, especially in the aggressive forms which can quickly progress to untreatable forms. The development of an easy, fast, and sensitive analytical tool with indicative applications in diagnosis and follow-up care, that could bring benefits in the discovery of new malignant diseases or relapses is reported. Oncofetal antigen/immature laminin receptor protein (OFA/iLRP) is an immunogenic protein found in fetal cells as well as overexpressed on the surface of some malignant tumors, including some hematologic malignancies. An aptamer, AB3, was selected and reported in the literature, having as a target the immature laminin receptor protein. Using the AB3 aptamer and its affinity to immature laminin receptor protein-positive cells an aptasensor was developed and tested on Jurkat cells. For the immobilization of the aptamer, graphene oxide modified screen printed electrodes were used and subjected to an activation procedure. The aptasensor development and cell caption were evaluated using electrochemical methods as well as microscopic techniques. The limit of detection of the developed aptasensor was 3.3 × 103 cells mL−1, meaning 16 cells in the 5 µL of suspension tested.